Management of Essential Tremor prioritizes functional improvement over symptom elimination, and protocols begin with ...

Cala Health, a wearable neuromodulation therapy startup focused on chronic diseases, has closed a $50 million Series C financing round. Novartis, Baird Capital, LifeSci Venture Partners, TriVentures ...

Cala announced the appointment of Deanna Harshbarger as Chief Executive Officer (CEO) and as a member of the Company's Board of Directors, effective immediately. Concurrently, Cala has appointed ...

Treatment options for essential tremor include medications, exercises, lifestyle changes, and in severe cases, surgical procedures such as deep brain stimulation. Essential tremor is a neurological ...

BURLINGAME, Calif.--(BUSINESS WIRE)--Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, announced that the U.S. Food and Drug Administration (FDA) ...

Some people very often experience an uncontrollable shaking of their hands or different body parts. Medically, the condition is called an essential tremor. It is when tremors shake your different body ...

This Daytime segment is sponsored by Tampa General Hospital. Parkinson’s Disease Awareness Month, observed in April, is a vital time to raise awareness and support for those affected by this ...

The International Neuromodulation Society (INS) recognized its third Giant of Neuromodulation at its 12th World Congress in Montreal in June - the first such awardee who is renowned for work in ...

SAN DIEGO--(BUSINESS WIRE)--Encora Therapeutics today announced that its abstract, Safety and Efficacy of a Wrist-worn Vibratory Stimulation Wearable for Upper Limb Tremor Reduction in Essential ...

"It isexciting to see how the strong and broad clinical evidence for TAPS Therapy has opened doors for patients to treat their tremor. TAPS Therapymakes essential daily activities such as eating, ...

— Encora breakthrough pivotal data demonstrating superiority over sham recognized as top rated Movement Disorders abstract — Encora Therapeutics today announced that its abstract, Safety and Efficacy ...